TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›XAGE›Financials
Annual statements · SEC XBRL · FY2021 – FY2025

Longevity Health Holdings, Inc. (XAGE) financials

Income statement

Longevity Health Holdings, Inc. (XAGE) income statement, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue——$0.00$50.3K$1.91M
Revenue growth————3701.4%
Gross profit——$0.00$44.0K$1.09M
Gross margin———87.4%57.2%
Operating income-$467K-$5.51M-$5.94M-$5.00M-$7.11M
Operating margin———-9933.8%-371.6%
Net income-$329K-$9.05M-$15.4M-$10.4M-$6.91M
Net margin———-20605.5%-361.0%
EPS (diluted)—-$5.47-$1.46-$14.56-$4.83

Cash flow

Longevity Health Holdings, Inc. (XAGE) cash flow, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Operating cash flow-$451K-$3.43M-$8.35M-$3.89M-$3.33M
Capital expenditures—$7.16K$30.5K—$14.2K
Free cash flow—-$3.44M-$8.38M—-$3.34M
Share buybacks—$2.29K$0.00——

Balance sheet

Longevity Health Holdings, Inc. (XAGE) balance sheet, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Cash & equivalents$0.00$128K$2.91M$157K$707K
Total assets$155M$1.75M$63.9M$1.47M$2.37M
Total liabilities$5.74M$8.12M$39.2M$6.19M$8.23M
Shareholders' equity-$29.6M-$37.8M$24.7M-$4.71M-$5.87M
Retained earnings-$4.76M-$42.4M-$58.5M-$68.9M-$75.8M
Shares (wtd avg diluted)—1.76M11.0M712K1.43M

Every figure is extracted from Longevity Health Holdings, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Longevity Health Holdings, Inc.'s annual revenue?
Longevity Health Holdings, Inc. (XAGE) reported $1.91M of revenue for fiscal year 2025 — up 3701.4% from $50.3K in FY2024, per its annual report filed with the SEC.
Is Longevity Health Holdings, Inc. profitable?
Not in FY2025 — XAGE reported a net loss of $6.91M, per SEC filings.
What is Longevity Health Holdings, Inc.'s free cash flow?
-$3.34M in FY2025 (operating cash flow -$3.33M minus $14.2K of capital expenditures), from the SEC cash-flow statement.
Does XAGE pay a dividend?
Longevity Health Holdings, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full XAGE analysis — verdict, score & filings →Is XAGE a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.